In vitro bacteriostatic and bactericidal activity of meropenem against multiresistant Pseudomonas aeruginosa.

被引:0
作者
Delisle, F
Lesage, D
Barakett, V
Richard, G
Petit, JC
机构
来源
PATHOLOGIE BIOLOGIE | 1996年 / 44卷 / 05期
关键词
meropenem; P-aeruginosa; bacteriostatic activity; killing curves;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Meropenem is a new dehydropeptidase stable carbapenem which has an in vitro bacteriostatic activity superior to imipenem against Pseudomonas aeruginosa. Minimal inhibitory concentrations of meropenem (MEM) and imipenem (IPM) were determined on twelve strains : two were genetically characterized reference strains and ten isolated from patients. Killing curves were performed for MEM used at 1,2 and 4 fold the MIC and 32 mg/l; survivors were counted at baseline and after 5 and 24 hours of incubation by spiral plating. Five strains were susceptible to MEM and IPM; five were intermediate and two resistant to MEM; these seven strains were resistant to IPM. A weak bactericidal effect was obtained after 5 h at each concentration. Only one strain achieved a 3 log(10) reduction after 5 h at 2 x MIC. A regrowth of all the strains tested was observed after 24 h.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
[41]   In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients [J].
Dassner, Aimee M. ;
Sutherland, Christina ;
Girotto, Jennifer ;
Nicolau, David P. .
INFECTIOUS DISEASES AND THERAPY, 2017, 6 (01) :129-136
[42]   Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm [J].
Mona Shaban E. M. Badawy ;
Walid F. Elkhatib ;
Rania I. Shebl .
Annals of Clinical Microbiology and Antimicrobials, 22
[43]   In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains [J].
Flynn, CM ;
Johnson, DM ;
Jones, RN .
JOURNAL OF CHEMOTHERAPY, 1996, 8 (06) :411-415
[44]   In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans-Bacterial Biofilms [J].
Osmani, Agim ;
Keceli, Sema Askin ;
Er, Doganhan Kadir ;
Uzuner, Huseyin ;
Ercan, Feriha ;
Koroglu, Ayca Karagoz .
APMIS, 2025, 133 (07)
[45]   Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa [J].
Monogue, Marguerite L. ;
Nicolau, David P. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (04) :942-952
[46]   Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence [J].
Bakthavatchalam, Yamuna Devi ;
Shankar, Abirami ;
Sethuvel, Dhiviya Prabaa Muthuirulandi ;
Asokan, Kalaiarasi ;
Kanthan, Kalaiarasi ;
Veeraraghavan, Balaji .
FUTURE SCIENCE OA, 2020, 6 (04)
[47]   In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing blaKPC or blaNDM [J].
Kuai, Junyang ;
Zhang, Yawei ;
Lu, Binghuai ;
Chen, Hongbin ;
Zhang, Yulin ;
Li, Henan ;
Wang, Yuanyuan ;
Wang, Qi ;
Wang, Hui ;
Wang, Xiaojuan .
INFECTION AND DRUG RESISTANCE, 2023, 16 :3171-3182
[48]   In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations [J].
Santerre Henriksen, Anne ;
Arena, Fabio ;
Attwood, Marie ;
Canton, Rafael ;
Gatermann, Soren ;
Naas, Thierry ;
Morrissey, Ian ;
Longshaw, Christopher .
MICROBIOLOGY SPECTRUM, 2024, 12 (08)
[49]   Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa [J].
Martinez, Melina ;
Goncalves, Sonia ;
Felicio, Mario R. ;
Maturana, Patricia ;
Santos, Nuno C. ;
Semorile, Liliana ;
Hollmann, Axel ;
Maffia, Paulo C. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2019, 1861 (07) :1329-1337
[50]   In vitro antimicrobial activity of liposomes containing ciprofloxacin, meropenem and gentamicin against gram-negative clinical bacterial strains [J].
Gubernator, Jerzy ;
Druis-Kawa, Zuzanna ;
Dorotkiewicz-Jach, Agata ;
Doroszkiewicz, Wlodzimierz ;
Kozubek, Arkadiusz .
LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (04) :297-304